• No image available for this medication
    • RYSTIGGO

    • QTY 2
    • 280 MG/2ML
    • VIAL
    • Near  77381

ROZANOLIXIZUMAB (roz AN oh lix IZ ue mab) treats myasthenia gravis, a condition that causes muscles to easily weaken or fatigue. It works by decreasing muscle weakness and loss of movement. It is a monoclonal antibody.


RYSTIGGO Information

En Español En Español

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment. Drug information is sourced from GSDD (Gold Standard Drug Database ) provided by Elsevier.